Clinical Trial Update: Adjuvant Cerebroprotection Using Normobaric Hyperoxia in Pre-hospital Patients with Suspected Stroke [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing normobaric hyperoxia for cerebroprotection in pre-hospital patients with suspected stroke; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Capital Medical University | Conditions: Stroke Acute | Phase 3 | Status: NOT_YET_RECRUITING